diabetes-related), and the specific Medvi medicine prescribed
Though it tracks basic protein intake, its not linked to any broader food database
As shown in Figure 2 , following stimulation of GLP-1R by exenatide on microglia, the cAMP/PKA/p38/CREB signal transduction pathway is activated, promoting the expression of IL-10
HR 1.19, 95% CI 0.91.58), but not for the other DPP-4 inhibitors as in the TECOS study for sitagliptin (HR 1.00, 95% CI 0.831.20) or the CARMELINA study for linagliptin (HR 0.90, 95% CI 0.741.08) (57, 62, 64, 65, 68)
Switching back to mammalian models (hamster, rats, pigs), researchers found that GLP-1 could stimulate insulin secretion and inhibit glucagon release, which could vastly benefit diabetic patients
The Bottom Line Success on GLP-1 medications isn't just about taking your weekly injectionit's about pairing that medication with a strategic nutrition approach that preserves muscle, minimizes side effects, and sets you up for long-term sustainable weight loss